MCM5 performed better in primary bladder cancer diagnosis, with a sensitivity of 74% and a specificity of 78%, making it a potentially helpful tool for symptomatic patients undergoing initial examination. This evidence concerns the gene MCM5 and urinary bladder carcinoma.